- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Matinas BioPharma Holdings Inc (MTNB)
3.4800
+0.3100(+9.78%)
Closed
After Hours
3.3100-0.1700(-4.8851%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1600
3.6000
52 wk Range
2.9500
21.5000
MTNB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Matinas BioPharma Holdings Inc stock price live, this page displays NYSE MTNB stock exchange data. View the MTNB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Matinas BioPharma Holdings Inc real time stock price chart below.
What Is the Matinas BioPharma Holdings Inc Stock Price Today?
The Matinas BioPharma Holdings Inc stock price today is 3.4800.
What Is the Stock Symbol for Matinas BioPharma Holdings Inc?
The stock ticker symbol for Matinas BioPharma Holdings Inc is MTNB.
Is MTNB the Same as $MTNB?
$MTNB is a common way to refer to the Matinas BioPharma Holdings Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Matinas BioPharma Holdings Inc Trade On?
Matinas BioPharma Holdings Inc is listed and trades on the NYSE stock exchange.
Is Matinas BioPharma Holdings Inc a Good Stock to Buy?
Determining whether Matinas BioPharma Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Matinas BioPharma Holdings Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MTNB quote. (ISIN: US5768103039)
What Is the Matinas BioPharma Holdings Inc Stock Price Today?
The Matinas BioPharma Holdings Inc stock price today is 3.4800.
What Is the Stock Symbol for Matinas BioPharma Holdings Inc?
The stock ticker symbol for Matinas BioPharma Holdings Inc is MTNB.
Is MTNB the Same as $MTNB?
$MTNB is a common way to refer to the Matinas BioPharma Holdings Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Matinas BioPharma Holdings Inc Trade On?
Matinas BioPharma Holdings Inc is listed and trades on the NYSE stock exchange.
Is Matinas BioPharma Holdings Inc a Good Stock to Buy?
Determining whether Matinas BioPharma Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Matinas BioPharma Holdings Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MTNB quote. (ISIN: US5768103039)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.16003.6000
52 wk Range
2.950021.5000
UnlockMTNB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
40.0000
Upside
+1,049.4253%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Matinas BioPharma implements reverse stock split
- Investing.com
- Matinas BioPharma stock hits 52-week low at $4.49
- Investing.com
- Matinas BioPharma implements reverse stock split
- Investing.com
- Matinas BioPharma stock hits 52-week low at $4.49
- Investing.com
- Matinas BioPharma enacts reverse stock split
- Investing.com
Matinas BioPharma Holdings Inc Company Profile
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company’s LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It also offers MAT2501, an orally administered formulation of amikacin to treat chronic and acute bacterial infections, as well as non-tuberculosis mycobacterium. The company has strategic collaborations with the National Institute of Allergy and Infectious Diseases for the development of oral formulations of Gilead’s remdesivir; BioNTech SE to evaluate the combination of mRNA formats with the LNC platform; and Genentech Inc. to develop oral formulations. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.
Compare MTNB to Peers and Sector
Metrics to compare | MTNB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMTNBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.1x | −0.6x | |
PEG Ratio | 0.11 | 0.06 | 0.00 | |
Price / Book | 0.9x | 3.2x | 2.6x | |
Price / LTM Sales | - | 19.7x | 3.2x | |
Upside (Analyst Target) | - | 180.5% | 49.1% | |
Fair Value Upside | Unlock | 18.6% | 7.2% | Unlock |
People Also Watch
FAQ
What Is the Matinas BioPharma (MTNB) Stock Price Today?
The Matinas BioPharma stock price today is 3.48
What Stock Exchange Does Matinas BioPharma Trade On?
Matinas BioPharma is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Matinas BioPharma?
The stock symbol for Matinas BioPharma is "MTNB."
What Is the Matinas BioPharma Market Cap?
As of today, Matinas BioPharma market cap is 17.46M.
What is Matinas BioPharma Earnings Per Share?
The Matinas BioPharma EPS is -5.08.
What Is the Next Matinas BioPharma Earnings Date?
Matinas BioPharma will release its next earnings report on Nov 06, 2024.
From a Technical Analysis Perspective, Is MTNB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.